|
Headache as primary symptom (505)
|
162 (32.1%)
|
50 (9.9%)
|
170 (33.7%)
|
58 (11.5%)
|
63 (12.5%)
|
1 (0.2%)
|
1 (0.2%)
| |
|
Headache as primary illness (75)
|
26 (34.7%)
|
8 (10.7%)
|
22 (29.3%)
|
9 (12%)
|
8 (10.7%)
|
1 (1.3%)
|
1 (1.3%)
| |
|
Chronic pain as primary illness (598)
|
179 (29.9%)
|
56 (9.4%)
|
183 (30.6%)
|
120 (20.1%)
|
56 (9.4%)
|
1 (0.17%)
| |
3 (0.5%)
|
|
Arthritis as primary illness (188)
|
70 (37.2%)
|
16 (8.5%)
|
60 (31.9%)
|
36 (19.2%)
|
4 (2.1%)
| | |
2 (1.1%)
|
|
3 Yes (343)a
|
109 (31.8%)
|
37 (10.8%)
|
120 (35%)
|
37 (10.8%)
|
39 (11.4%)
| |
1 (0.29%)
| |
|
2 Yes (102)b
|
34 (33.3%)
|
9 (8.8%)
|
29 (28.4%)
|
11 (10.8%)
|
19 (18.6%)
| | | |
|
3 + 2 Yes (445)
|
143 (32.1%)
|
46 (10.3%)
|
149 (33.5%)
|
48 (10.8%)
|
58 (13%)
| | | |
|
Mental Health Condition (548) + PTSD (93)
|
184 (28.7%)
|
89 (13.9%)
|
195 (30.4%)
|
74 (11.5%)
|
97 (15.1%)
|
1 (0.16%)
|
1 (0.16%)
| |
|
Insomnia/Sleep Disorder (198)
|
63 (31.8%)
|
19 (9.6%)
|
65 (32.8%)
|
30 (15.2%)
|
19 (9.6%)
|
1 (0.51%)
| |
1 (0.51%)
|
|
Gastrointestinal Disorder (62) + Crohn’s Disease (35)
|
34 (35.1%)
|
12 (12.4%)
|
26 (26.8%)
|
11 (11.3%)
|
14 (14.4%)
| | | |
|
Overall Medicinal Cannabis Cohort (2032)
|
632 (31.1%)
|
229 (11.3%)
|
617 (30.4%)
|
330 (16.2%)
|
212 (10.4%)
|
4 (0.20%)
|
2 (0.10%)
|
6 (0.30%)
|
